H
Hubert de Boysson
Researcher at University of Caen Lower Normandy
Publications - 91
Citations - 1991
Hubert de Boysson is an academic researcher from University of Caen Lower Normandy. The author has contributed to research in topics: Giant cell arteritis & Vasculitis. The author has an hindex of 18, co-authored 73 publications receiving 1213 citations. Previous affiliations of Hubert de Boysson include Paris Descartes University.
Papers
More filters
Journal ArticleDOI
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Bernhard Hellmich,Ana Filipa Águeda,Sara Monti,Frank Buttgereit,Hubert de Boysson,Elisabeth Brouwer,Rebecca Cassie,Maria C. Cid,Bhaskar Dasgupta,Christian Dejaco,Gulen Hatemi,Nicole Hollinger,Alfred Mahr,Susan P Mollan,Chetan Mukhtyar,Cristina Ponte,Carlo Salvarani,Rajappa Sivakumar,Xinping Tian,Gunnar Tomasson,Carl Turesson,Wofgang Schmidt,Peter M. Villiger,Richard A. Watts,Chris Young,Raashid Luqmani +25 more
TL;DR: The recommendations for the management of LVV have been updated to facilitate the translation of current scientific evidence and expert opinion into better management and improved outcome of patients in clinical practice.
Journal ArticleDOI
Primary Angiitis of the Central Nervous System: Description of the First Fifty-Two Adults Enrolled in the French Cohort of Patients With Primary Vasculitis of the Central Nervous System
Hubert de Boysson,Mathieu Zuber,Olivier Naggara,Jean-Philippe Neau,Françoise Gray,Marie-Germaine Bousser,Isabelle Crassard,Emmanuel Touzé,Pierre-Olivier Couraud,Philippe Kerschen,Catherine Oppenheim,Olivier Detante,Anthony Faivre,Nicolas Gaillard,Caroline Arquizan,Boris Bienvenu,Antoine Néel,Loïc Guillevin,Christian Pagnoux +18 more
TL;DR: Characteristics and outcomes of a multicenter cohort of patients diagnosed as having primary angiitis of the central nervous system (PACNS) are described.
Journal ArticleDOI
Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients.
Hubert de Boysson,Aurélie Daumas,Mathieu Vautier,Jean-Jacques Parienti,Eric Liozon,Marc Lambert,Maxime Samson,Mikael Ebbo,A. Dumont,Audrey Sultan,Bernard Bonnotte,Alain Manrique,Boris Bienvenu,David Saadoun,Achille Aouba +14 more
TL;DR: Large-vessel involvement (LVI) can occur in giant-cell arteritis (GCA) and may represent a distinct disease subgroup with a higher risk for aortic dilation with an increased risk of aorta dilation.
Journal ArticleDOI
Giant Cell Arteritis-related Stroke: A Retrospective Multicenter Case-control Study.
Hubert de Boysson,Eric Liozon,Delphine Larivière,Maxime Samson,Jean-Jacques Parienti,Jonathan Boutemy,Gwenola Maigne,Nicolas Martin Silva,Kim Heang Ly,Emmanuel Touzé,Bernard Bonnotte,Achille Aouba,Karim Sacre,Boris Bienvenu +13 more
TL;DR: Stroke, especially in the vertebrobasilar territory, is more likely to occur in patients with GCA who experience recent ophthalmic ischemic symptoms and who exhibit low inflammatory variables.
Journal ArticleDOI
Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
Hubert de Boysson,Jonathan Boutemy,Christian Creveuil,Yann Ollivier,Philippe Letellier,Christian Pagnoux,Boris Bienvenu +6 more
TL;DR: Cyclophosphamide is an interesting option for GCA patients with GC-dependent disease or with severe GC-related side effects, especially when conventional immunosuppressive agents have failed.